Booth R G, Baldessarini R J, Campbell A
Department of Psychiatry, Harvard Medical School, Boston, MA.
Biochem Pharmacol. 1991 Jun 15;41(12):2040-3. doi: 10.1016/0006-2952(91)90148-x.
This study provides in vitro evidence that rats pretreated with fluphenazine for 10 days, but not acutely, developed moderate but significant striatal autoreceptor supersensitivity as measured by the ability of S(+)-NPA, a selective DA autoreceptor agonist and very weak postsynaptic agonist, to inhibit tyrosine hydroxylase activity. In contrast, autoreceptor supersensitivity was not found with the nonselective auto- and postsynaptic receptor agonist R(-)-NPA. Presumably, this effect represents some modification of a presynaptic regulatory mechanism controlling DA synthesis which can occur despite a reportedly high striatal DA autoreceptor reserve in rat striatum [2, 7]. Such a mechanism, by tending to reduce synaptic availability of DA, may contribute to tolerance to the transient, early DA-synthesis stimulating actions of acutely administered neuroleptics [4], and help to counterbalance increases in postsynaptic DA receptor abundance and sensitivity associated with long-term neuroleptic treatment.
本研究提供了体外证据,表明用氟奋乃静预处理10天而非急性处理的大鼠,产生了中度但显著的纹状体自身受体超敏反应,这是通过选择性DA自身受体激动剂和非常弱的突触后激动剂S(+)-NPA抑制酪氨酸羟化酶活性的能力来衡量的。相比之下,非选择性自身和突触后受体激动剂R(-)-NPA未发现自身受体超敏反应。据推测,这种效应代表了控制DA合成的突触前调节机制的某种改变,尽管据报道大鼠纹状体中纹状体DA自身受体储备较高,但这种改变仍可能发生[2,7]。这种机制倾向于降低DA的突触可用性,可能有助于对急性给予的抗精神病药物短暂的早期DA合成刺激作用产生耐受性[4],并有助于抵消与长期抗精神病药物治疗相关的突触后DA受体丰度和敏感性的增加。